20 June 2013
Keywords: immunex, gain, control, gm-csf, market, set, become
Article | 03 August 1992
Immunex is set to become the sole marketer of granulocyte macrophage
colony stimulating factor in the USA, following an agreement ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
3 August 1992
19 June 2013
© 2013 thepharmaletter.com